Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells
about
Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and CancerGD2 expression in breast cancer.NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression.GD2-targeted immunotherapy and radioimmunotherapyHuman breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma.Convergence and divergence of genetic and modular networks between diabetes and breast cancer.Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to MalignancyI-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signalingDiscovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patientsGlycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations.A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor.Cancer stem cell marker glycosylation: Nature, function and significance.Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults.Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody.Structure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2.Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.Functional role of glycosphingolipids in contact inhibition of growth in a human mammary epithelial cell line.TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression.Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial.Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
P2860
Q26742115-32C81A2C-E14C-49B7-B6EE-CE944D189F9FQ28077907-B732E203-1E07-4BAB-9281-E84549015F66Q33761830-8EA5D686-87B1-49E1-BC07-ABB6FD21C127Q34129082-48362075-AE42-40FF-981F-3FA11DE42247Q34389202-1B7938D0-6620-4F68-BD56-E73BD1E23FB4Q34499844-69CA0678-C7DC-4D8B-B41A-0162BC85BB18Q34625339-7ED9CED5-8EBE-4CEA-9C42-12D6DA019C3AQ34897367-2673B4C0-5A65-487E-8870-CC89485952EDQ35030373-3A2FF2A3-2A8E-407F-BEAC-EFA6F9C9D6E6Q35571951-B9110A28-3DDB-48D7-B91B-749EFAAC80DFQ35679876-F4D5D6F2-D9C3-4E00-8F4D-D8118B960269Q36746278-4D601C5E-D116-44A4-8A4C-EA7DC96D6720Q37159825-B1BFD5DF-0B72-4E2D-9EF5-2B8C0DFB1651Q37487019-62FB311E-6EC0-4E32-AB78-2B2E20A77217Q38203883-804471AB-3246-4CD0-A263-43D4874A578AQ38285674-C286ED5E-0933-4028-AF9C-983BF5D03242Q38740257-81250A59-1E86-449E-B14B-DA967B5D08F6Q39380552-E85A4AD7-46C1-4948-ABE7-18886987C60BQ40267794-F42AAE61-7F93-4A2D-BA7F-391C8E2C6271Q40700335-D7FAA3F4-C997-4559-964A-26E2CD1C1408Q41471118-B7A63A41-35DE-40AA-9360-68A523092EACQ41590699-3B74C146-FD58-47ED-BDDB-D233AFD87D02Q42079963-677420D6-5ED4-44F3-8265-E3B8B9502DA1Q44845721-3261E4AE-9EBB-47C5-96BA-E9DAE00D6987Q47135344-56FFB6A9-CD1C-44E8-B711-CD6891BD2078Q50957360-4F99A15B-71FB-4C4C-9BDD-084C565EF3CFQ52308844-6CBCA285-74A3-4DFB-82D3-DE817C2ABFAAQ54943815-CD2D2BD5-F02F-489D-94D1-3D97A4A65DEBQ55173262-0A1B67B5-A510-49F1-A046-3DC26465DEF3Q58765307-8FA84B8F-A330-4E6A-BE2C-DE9D66BBF7F8
P2860
Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Differential expression profil ...... ells vs. cancer non-stem cells
@ast
Differential expression profil ...... ells vs. cancer non-stem cells
@en
type
label
Differential expression profil ...... ells vs. cancer non-stem cells
@ast
Differential expression profil ...... ells vs. cancer non-stem cells
@en
prefLabel
Differential expression profil ...... ells vs. cancer non-stem cells
@ast
Differential expression profil ...... ells vs. cancer non-stem cells
@en
P2093
P2860
P356
P1476
Differential expression profil ...... ells vs. cancer non-stem cells
@en
P2093
Kazuko Handa
Marlin Lobaton
Sen-itiroh Hakomori
Steven B Levery
Yuh-Jin Liang
P2860
P304
P356
10.1073/PNAS.1302825110
P407
P577
2013-03-11T00:00:00Z